NCT00476554 2021-12-22A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaCyclacel Pharmaceuticals, Inc.Phase 2 Terminated16 enrolled
NCT01253460 2019-09-06Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)M.D. Anderson Cancer CenterPhase 2 Terminated18 enrolled 10 charts